Recovery
KPV
Also called Lys-Pro-Val
per administration
Only animal or lab studies exist — no human study has set an amount.
Quick start
KPV at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 200–500 mcg per administration
- How often
- Every day
- Where
- Commonly subcutaneous Sites and rotation
- Time to steady level
- ~3 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Key properties
Molecular reference data.
- Formula
- C16H30N4O4
- Mol. weight
- 342.43 Da
- CAS
- 67727-97-3
- PubChem CID
- 125672
Sequence (one-letter)
KPV
External references
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for KPV describe 200–500 mcg per administration. Descriptive only, not a recommendation.
A tripeptide cleared quickly by serum peptidases; human PK is thin, and most work is rodent or topical.
Evidence is preclinical; no human study fixes an amount or schedule, so no schedule table is shown.
What it can be combined with
How KPV is commonly discussed alongside other peptides and drugs.
Educational reference on commonly-discussed combinations, not medical advice. Combining compounds can change how each behaves — read this as a prompt to research, not a clearance.
- KLOWKLOW already contains KPV, so a standalone vial stacks on the blend's share.Use caution
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 3hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- α-MSH / KPV anti-inflammatory literatureMostly rodent and cell models; human injectable amounts are extrapolated.